DE69933128D1 - Pharmazeutische zusammensetzungen zur behandlung von erektiler dysfunktion - Google Patents

Pharmazeutische zusammensetzungen zur behandlung von erektiler dysfunktion

Info

Publication number
DE69933128D1
DE69933128D1 DE69933128T DE69933128T DE69933128D1 DE 69933128 D1 DE69933128 D1 DE 69933128D1 DE 69933128 T DE69933128 T DE 69933128T DE 69933128 T DE69933128 T DE 69933128T DE 69933128 D1 DE69933128 D1 DE 69933128D1
Authority
DE
Germany
Prior art keywords
treatment
dysfunction
effective
pharmaceutical compositions
alprostadil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69933128T
Other languages
English (en)
Other versions
DE69933128T2 (de
Inventor
S Podolski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Repros Therapeutics Inc
Original Assignee
Zonagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zonagen Inc filed Critical Zonagen Inc
Application granted granted Critical
Publication of DE69933128D1 publication Critical patent/DE69933128D1/de
Publication of DE69933128T2 publication Critical patent/DE69933128T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69933128T 1998-09-17 1999-09-17 Pharmazeutische zusammensetzungen zur behandlung von erektiler dysfunktion Expired - Lifetime DE69933128T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US154677 1998-09-17
US09/154,677 US6482426B1 (en) 1998-09-17 1998-09-17 Compositions for the treatment of male erectile dysfunction
PCT/US1999/021513 WO2000015233A1 (en) 1998-09-17 1999-09-17 Compositions for the treatment of male erectile dysfunction

Publications (2)

Publication Number Publication Date
DE69933128D1 true DE69933128D1 (de) 2006-10-19
DE69933128T2 DE69933128T2 (de) 2007-08-16

Family

ID=22552291

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69933128T Expired - Lifetime DE69933128T2 (de) 1998-09-17 1999-09-17 Pharmazeutische zusammensetzungen zur behandlung von erektiler dysfunktion

Country Status (12)

Country Link
US (3) US6482426B1 (de)
EP (1) EP1112075B1 (de)
JP (1) JP4721517B2 (de)
CN (1) CN1338939B (de)
AT (1) ATE338554T1 (de)
AU (1) AU772922B2 (de)
CA (1) CA2344435C (de)
DE (1) DE69933128T2 (de)
DK (1) DK1112075T3 (de)
ES (1) ES2273509T3 (de)
PT (1) PT1112075E (de)
WO (1) WO2000015233A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6905707B2 (en) * 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
US6482426B1 (en) * 1998-09-17 2002-11-19 Zonagen, Inc. Compositions for the treatment of male erectile dysfunction
US6476037B1 (en) 2000-03-23 2002-11-05 The Regents Of The University Of California L-arginine and phosphodiesterase (PDE) inhibitor synergism
CN1315504A (zh) * 2000-03-24 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人磷酸核糖甘氨酰胺合成酶12和编码这种多肽的多核苷酸
EP1762236B1 (de) * 2000-05-12 2015-07-15 Septodont Holding SAS Formulierungen von alpha-adrenergen Rezeptor-Antagonisten und ihre Anwendungen
GB2375303A (en) * 2001-05-11 2002-11-13 Medical Res Council Method of inducing cervical ripening
DE10142418A1 (de) * 2001-08-31 2003-04-03 Molecular And Clinical Drug Re Arzneimittel
AU2003247568B2 (en) * 2002-06-20 2008-03-06 Septodont Holding Sas Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof
US7037257B1 (en) * 2002-08-22 2006-05-02 Koenig J Frank Erectile dysfuction treatments comprising momentary vacuum therapy alone or with medications
KR20040043996A (ko) * 2002-11-20 2004-05-27 조나겐, 아이엔씨. 남성 발기부전치료를 위한 개선된 조성물
JP4615929B2 (ja) * 2004-08-11 2011-01-19 久光製薬株式会社 イオントフォレーシス装置
EP1909813A4 (de) * 2005-07-25 2009-09-09 Therimunex Llc Peptidyl-diacylglyceride
US7862598B2 (en) * 2007-10-30 2011-01-04 The Invention Science Fund I, Llc Devices and systems that deliver nitric oxide
US20090110933A1 (en) * 2007-10-30 2009-04-30 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems and devices related to nitric oxide releasing materials
US20090112197A1 (en) 2007-10-30 2009-04-30 Searete Llc Devices configured to facilitate release of nitric oxide
US8221690B2 (en) * 2007-10-30 2012-07-17 The Invention Science Fund I, Llc Systems and devices that utilize photolyzable nitric oxide donors
US20110190604A1 (en) * 2006-12-22 2011-08-04 Hyde Roderick A Nitric oxide sensors and systems
US8642093B2 (en) * 2007-10-30 2014-02-04 The Invention Science Fund I, Llc Methods and systems for use of photolyzable nitric oxide donors
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
EP2014651A1 (de) * 2007-07-12 2009-01-14 Exonhit Therapeutics SA Verbindungen und Verfahren zur Modulierung von Rho-GTPasen
US8349262B2 (en) * 2007-10-30 2013-01-08 The Invention Science Fund I, Llc Nitric oxide permeable housings
US10080823B2 (en) 2007-10-30 2018-09-25 Gearbox Llc Substrates for nitric oxide releasing devices
US20090112193A1 (en) * 2007-10-30 2009-04-30 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems and devices that utilize photolyzable nitric oxide donors
US7897399B2 (en) 2007-10-30 2011-03-01 The Invention Science Fund I, Llc Nitric oxide sensors and systems
US8877508B2 (en) * 2007-10-30 2014-11-04 The Invention Science Fund I, Llc Devices and systems that deliver nitric oxide
US20090112055A1 (en) * 2007-10-30 2009-04-30 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Sleeves configured to facilitate release of nitric oxide
US8980332B2 (en) 2007-10-30 2015-03-17 The Invention Science Fund I, Llc Methods and systems for use of photolyzable nitric oxide donors
US20090259214A1 (en) * 2008-04-09 2009-10-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Agent delivery device
US20090259217A1 (en) * 2008-04-09 2009-10-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems associated with delivery of one or more agents to an individual
WO2010070617A1 (en) * 2008-12-19 2010-06-24 Shimoda Biotech (Pty) Ltd Inclusion complexes of alpha-cyclodextrin and sildenafil salt
JP5841608B2 (ja) * 2010-11-12 2016-01-13 コルゲート・パーモリブ・カンパニーＣｏｌｇａｔｅ−Ｐａｌｍｏｌｉｖｅ Ｃｏｍｐａｎｙ 口腔ケア製品およびその使用方法および製造方法
US8560453B2 (en) 2011-06-30 2013-10-15 Intel Corporation Method and apparatus for dynamic, real-time ad insertion based on meta-data within a hardware based root of trust
US20130303566A1 (en) * 2012-05-09 2013-11-14 David W. Hill Method for treating macular degeneration
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
WO2018220232A1 (en) * 2017-06-02 2018-12-06 Universite De Versailles-St Quentin En Yvelines Pharmaceutical combination product comprising botulinum toxin for the treatment of erectile dysfunction
CN109820820B (zh) * 2019-02-25 2021-12-21 浙江长典药物技术开发有限公司 一种前列地尔注射液及其制备方法
CN110193011B (zh) * 2019-06-19 2022-02-11 四川美大康华康药业有限公司 一种甲磺酸酚妥拉明注射液及其制备方法
CN111789818B (zh) * 2020-08-15 2022-02-22 山东北大高科华泰制药有限公司 注射用盐酸罂粟碱药物组合物及制备方法
WO2022087496A1 (en) * 2020-10-22 2022-04-28 Standard International Group Holdings, LP Transdermal treatment for erectile dysfunction
CN113143868B (zh) * 2021-03-03 2022-04-12 海南久常制药有限公司 一种注射用盐酸罂粟碱及其制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3943246A (en) 1972-07-10 1976-03-09 Sandoz Ltd. Organic compounds
US4139617A (en) 1974-05-13 1979-02-13 Richardson-Merrell Inc. 19-Oxygenated-androst-5-enes for the enhancement of libido
US4127118B1 (en) 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US4746651A (en) * 1983-11-01 1988-05-24 Scripps Clinic And Research Foundation Antimicrobial chemotherapeutic potentiation using substituted nucleoside derivatives
US4530920A (en) 1983-11-07 1985-07-23 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH agonist
US4885173A (en) 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
US4863911A (en) 1986-08-04 1989-09-05 University Of Florida Method for treating male sexual dysfunction
US4801587A (en) 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5256652A (en) 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
SE463851B (sv) * 1988-09-02 1991-02-04 Amsu Ltd Komposition foer behandling av erektil dysfunktion via uretra
US5059603A (en) 1989-06-12 1991-10-22 Centuries Laboratories, Inc. Method and composition for treating impotence
WO1990015583A1 (en) 1989-06-16 1990-12-27 Vsesojuzny Nauchno-Issledovatelsky I Ispytatelny Institut Meditsinskoi Tekhniki Device for treating sexual weakness in men
FR2649613B1 (fr) 1989-07-11 1991-09-27 Virag Ronald Medicament vaso-actif
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5236904A (en) 1989-09-18 1993-08-17 Senetek, Plc Erection-inducing methods and compositions
US5270323A (en) 1990-05-31 1993-12-14 Pfizer Inc. Method of treating impotence
US5399581A (en) 1990-12-26 1995-03-21 Laragh; John H. Method and compositions for treatment of sexual impotence
US5298261A (en) 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
US5646181A (en) * 1992-07-02 1997-07-08 Research Foundation Of State University Of New York Method and compositions for treating impotence
US5565466A (en) 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
US6121276A (en) * 1994-04-22 2000-09-19 Pentech Pharmaceuticals, Inc. Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
US5731339A (en) 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response
DK172203B1 (da) * 1996-03-11 1998-01-05 Gitte Bjeldbak Elskovsmiddel, der virker seksuelt ophidsende på brugeren
AU749703B2 (en) * 1997-05-19 2002-07-04 Repros Therapeutics Inc. Combination therapy for modulating the human sexual response
US20020068365A1 (en) * 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
US6482426B1 (en) * 1998-09-17 2002-11-19 Zonagen, Inc. Compositions for the treatment of male erectile dysfunction

Also Published As

Publication number Publication date
AU5927099A (en) 2000-04-03
DE69933128T2 (de) 2007-08-16
CN1338939B (zh) 2012-07-04
JP2002524520A (ja) 2002-08-06
CN1338939A (zh) 2002-03-06
US20040102475A1 (en) 2004-05-27
JP4721517B2 (ja) 2011-07-13
CA2344435C (en) 2010-02-16
EP1112075B1 (de) 2006-09-06
ATE338554T1 (de) 2006-09-15
EP1112075A1 (de) 2001-07-04
WO2000015233A1 (en) 2000-03-23
CA2344435A1 (en) 2000-03-23
DK1112075T3 (da) 2006-12-27
US6482426B1 (en) 2002-11-19
US6696072B1 (en) 2004-02-24
US7776899B2 (en) 2010-08-17
AU772922B2 (en) 2004-05-13
PT1112075E (pt) 2006-12-29
ES2273509T3 (es) 2007-05-01

Similar Documents

Publication Publication Date Title
DE69933128D1 (de) Pharmazeutische zusammensetzungen zur behandlung von erektiler dysfunktion
HUP0001089A2 (hu) Gyógyászati készítmények férfiak erekciós zavarainak kezelésére
EA199700213A1 (ru) Крем на водной основе для локального применения, способ его приготовления, способ лечения эректильной дисфункции у мужчин, способ лечения аноргазма у женщин, способ лечения микроваскулярных заболеваний и способ лечения ран или хирургических рассечений
DE69802838D1 (de) Zusammensetzung und verfahren zur behandlung der erektilen disfunktion des penis
EA200001043A2 (ru) Соединения для лечения женской сексуальной дисфункции
DE69529173T2 (de) Heterozyklische bizykeln zur behandlung von impotenz
TR200103302T2 (tr) Diamorfin etkin maddeli farmasötik preparat
BR0308137A (pt) Formulações de droga de liberação constante contendo um peptìdeo veìculo
BR0305628A (pt) Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso
SE0001914D0 (sv) Förbättring av Peyronies sjukdom
IS2259B (is) Aðferð til meðferðar á netjuhersli með notkun mótlyfs við integríninu alfa-4 undireiningunni
HUP9902094A2 (hu) PGE-1-tartalmú liofilizált liposzómák erekciós zavar kezelésében való alkalmazásra
KR900005974A (ko) 남성의 성기능 장애 치료제
ATE228843T1 (de) Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit
MXPA02010115A (es) Composiciones mejoradas para el tratamiento de la disfuncion erectil masculina.
AR037563A1 (es) Composiciones mejoradas para el tratamiento de la disfuncion erectil masculina
BR0204206A (pt) Composições melhoradas para o tratamento de disfunção erétil masculina
BR0317292A (pt) Derivados de amida de ácido antranìlico e seu uso farmacêutico
NZ500640A (en) A method of preventing pregnancy using a composition of a condensation polymer of an aldehyde and an aromatic sulphonic acid
SE9802555D0 (sv) New pharmaceutical preparation and method
KR20010045152A (ko) 발기유발제
MD1469G2 (ro) Metodă de tratament al şocului combustional
TR200100414A2 (tr) Parasetamol yeni enjekte edilebilir çözeltileri ve aktif farmasötik maddeler ile kombinasyon halindeki enjekte edilebilir çözeltileri
UA29155A (uk) Спосіб лікування загрози передчасних пологів у жінокнаркоманок
RU97117167A (ru) Способ и набор для предотвращения нарушения эрекционной функции

Legal Events

Date Code Title Description
8364 No opposition during term of opposition